Ga onbeperkt met Magzter GOLD
Krijg onbeperkte toegang tot meer dan 9000 tijdschriften, kranten en Premium-verhalen voor slechts
Poging GOUD - Vrij
PLI boost: Cancer drugs to cost less
Mint New Delhi
|March 05, 2025
Cancer patients facing prohibitive treatment costs in India can hope for relief.
The nation's top drugmakers have started manufacturing key medicines for such diseases in the country.
India's largest drugmaker Sun Pharmaceutical Industries Ltd and its peers Cipla Ltd, Glenmark Pharmaceuticals Ltd, Cadila Healthcare Ltd and Biocon Ltd are making cancer drugs under the production-linked incentive (PLI) scheme, according to information shared by the department of pharmaceuticals with Mint. They are among the 55 companies selected for incentives to produce 175 high-value medicines in India.
At present, most cancer drugs are imported, making them prohibitively expensive. That's when India's cancer burden is expected to rise from 26.7 million life years or DALYS-the sum of healthy life lost to a disease-in 2021 to 29.8 million in 2025, according to data from the Indian Council of Medical Research (ICMR) disability-adjusted. The PLI scheme is a "great boon" as cancer drugs will not only become cheaper in India, but South American and southern African nations will also benefit, said Shyam Aggarwal, chairperson, medical oncology department at Sir Ganga Ram Hospital, Delhi.
Dit verhaal komt uit de March 05, 2025-editie van Mint New Delhi.
Abonneer u op Magzter GOLD voor toegang tot duizenden zorgvuldig samengestelde premiumverhalen en meer dan 9000 tijdschriften en kranten.
Bent u al abonnee? Aanmelden
MEER VERHALEN VAN Mint New Delhi
Mint New Delhi
Tobacco cess set to expire, enter health and national security cess
Finance minister Nirmala Sitharaman will introduce a bill in Lok Sabha on Monday to levy a new cess for public health and national security, replacing the GST compensation cess on tobacco, which will lapse when the Centre completes repayment of the loans raised to compensate states.
2 mins
December 01, 2025
Mint New Delhi
China used to be a cash cow for western companies. Now it’s a test lab.
For Western companies in China, a new reality has set in: The easy money is gone and competition is only getting fiercer.
4 mins
December 01, 2025
Mint New Delhi
BEHIND THE GLOSSY REPORT: THE MAKE BELIEVE ESG WORLD
Recently, the Sebi chairperson made a distinction that should make every company board squirm, Speaking at the “Gatekeepers of Governance’ summit, Tuhin Kanta Pandey separated “compliance” from “governance” in a way that was both elegant and damning.
2 mins
December 01, 2025
Mint New Delhi
Battery PLI may get new spark as rules set to ease
Scheme saw limited success; 50GWh capacity by Dec 2024 goal fell far short
3 mins
December 01, 2025
Mint New Delhi
Why MF vendors haven't grown as fast as MF assets
A rising tide does not lift all boats—an adage that mutual fund distributors will vouch for.
4 mins
December 01, 2025
Mint New Delhi
New safety, emission rules spell riches for parts firms
Anti-lock brakes? Sound alerts for EVs? Ever-changing emission norms? For India’s nimble auto parts makers, every new regulation to raise safety and lower pollution is opening up business avenues.
3 mins
December 01, 2025
Mint New Delhi
Smart GDP growth casts shadow over December rate cut
The Reserve Bank of India’s (RBI's) Monetary Policy Committee (MPC) is widely expected to keep the policy rate unchanged on 5 December, even as a sizable minority of economists argues that the space created by softening inflation and moderating nominal growth warrants another rate cut.
2 mins
December 01, 2025
Mint New Delhi
Early-stage funding climbs back, led by bigger cheques
This year's fundraising average is likely to surpass 2022, with more deals yet to be reported
2 mins
December 01, 2025
Mint New Delhi
Opec+ retains pause on oil supply hikes
The Organization of the Petroleum Exporting Countries and its partners (Opec+) will stick with plans to pause production increases during the first quarter, delegates said, amid growing signs of a surplus in global oil markets.
1 min
December 01, 2025
Mint New Delhi
Gen Alpha will make new rules for their workplace
Gen Alpha will expect hybrid workplaces, Al tools and 4-day weeks— offices unrecognizable to their parents’
3 mins
December 01, 2025
Listen
Translate
Change font size